Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials.
Palmerini T, Kirtane AJ, Serruys PW, Smits PC, Kedhi E, Kereiakes D, Sangiorgi D, Bacchi Reggiani L, Kaiser C, Kim HS, De Waha A, Ribichini F, Stone GW. Palmerini T, et al. Among authors: kim hs. Circ Cardiovasc Interv. 2012 Jun;5(3):357-64. doi: 10.1161/CIRCINTERVENTIONS.111.967083. Epub 2012 Jun 5. Circ Cardiovasc Interv. 2012. PMID: 22668554 Review.
Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, Park SW, Seung KB, Gwon HC, Jeong MH, Jang Y, Kim HS, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ; Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators. Kim YH, et al. Among authors: kim hs. Circulation. 2009 Aug 4;120(5):400-7. doi: 10.1161/CIRCULATIONAHA.108.800805. Epub 2009 Jul 20. Circulation. 2009. PMID: 19620506
Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent implantation for the complex coronary lesions: two-year clinical follow-up of COREA-TAXUS trial.
Chung JW, Yang HM, Park KW, Lee HY, Park JS, Kang HJ, Cho YS, Youn TJ, Koo BK, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Chung JW, et al. Among authors: kim hs. Circ Cardiovasc Interv. 2010 Jun 1;3(3):243-8. doi: 10.1161/CIRCINTERVENTIONS.109.889881. Epub 2010 May 18. Circ Cardiovasc Interv. 2010. PMID: 20484099 Clinical Trial.
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation.
Cho Y, Yang HM, Park KW, Chung WY, Choi DJ, Seo WW, Jeong KT, Chae SC, Lee MY, Hur SH, Chae JK, Seong IW, Yoon JH, Oh SK, Kim DI, Park KS, Rha SW, Jang YS, Bae JH, Hong TJ, Cho MC, Kim YJ, Jeong MH, Kim MJ, Park SK, Chae IH, Kim HS; KAMIR Investigators. Cho Y, et al. Among authors: kim yj, kim di, kim hs, kim mj. JACC Cardiovasc Interv. 2010 May;3(5):498-506. doi: 10.1016/j.jcin.2010.02.011. JACC Cardiovasc Interv. 2010. PMID: 20488406 Free article.
High plasma interleukin-6 is associated with drug-eluting stent thrombosis: possible role of inflammatory cytokines in the development of stent thrombosis from the Korea Stent Thrombosis Registry.
Hwang SJ, Park KW, Kwon DA, Kang HJ, Koo BK, Chae IH, Gwon HC, Park SJ, Seung KB, Ahn T, Yoon JH, Jang YS, Jeong MH, Tahk SJ, Kim HS; Korea Stent Thrombosis Investigators. Hwang SJ, et al. Among authors: kim hs. Circ J. 2011;75(6):1350-7. doi: 10.1253/circj.cj-10-0488. Epub 2011 Apr 18. Circ J. 2011. PMID: 21498913 Free article.
Characteristics and predictors of drug-eluting stent thrombosis: results from the multicenter 'Korea Stent Thrombosis (KoST)' registry.
Park KW, Hwang SJ, Kwon DA, Oh BH, Park YB, Chae IH, Gwon HC, Park SJ, Seung KB, Ahn T, Yoon JH, Jang YS, Jeong MH, Tahk SJ, Kim HS; Korea Stent Thrombosis Investigators. Park KW, et al. Among authors: kim hs. Circ J. 2011;75(7):1626-32. doi: 10.1253/circj.cj-10-1160. Epub 2011 May 28. Circ J. 2011. PMID: 21628837 Free article.
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.
Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Baber U, et al. Among authors: kim mc, kim hs. J Am Coll Cardiol. 2011 Oct 4;58(15):1569-77. doi: 10.1016/j.jacc.2011.06.049. Epub 2011 Sep 14. J Am Coll Cardiol. 2011. PMID: 21924575 Free article.
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
Gwon HC, Hahn JY, Park KW, Song YB, Chae IH, Lim DS, Han KR, Choi JH, Choi SH, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Jang Y, Kim HS. Gwon HC, et al. Among authors: kim hs, kim bo. Circulation. 2012 Jan 24;125(3):505-13. doi: 10.1161/CIRCULATIONAHA.111.059022. Epub 2011 Dec 16. Circulation. 2012. PMID: 22179532 Clinical Trial.
15,719 results
You have reached the last available page of results. Please see the User Guide for more information.